oru.sePublikationer
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Antibiotic susceptibility in prostate-derived Propionibacterium acnes isolates
Department of Clinical Microbiology, Umeå University, Umeå.
Department of Urology, Örebro University Hospital, Örebro, Sweden.
Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden.
Department of Laboratory Medicine, Clinical Microbiology, Örebro University Hospital, Örebro, Sweden.
Show others and affiliations
2012 (English)In: Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), ISSN 0903-4641, E-ISSN 1600-0463, Vol. 120, no 10, 778-785 p.Article in journal (Refereed) Published
Abstract [en]

The aim of this study was to determine antibiotic susceptibility of Propionibacterium acnes isolates from prostate. Prostate-derived P. acnes isolates (n = 24, Umea & Orebro, Sweden, 20072010) and a panel of control strains (n = 25, Sweden) collected from skin and deep infections were assessed for resistance to penicillin G, piperacillintazobactam, imipenem, gentamicin, azithromycin, erythromycin, vancomycin, ciprofloxacin, moxifloxacin, tetracycline, tigecycline, fusidic acid, clindamycin, rifampicin, linezolid, daptomycin, trimethoprimsulfamethoxazole, and metronidazole. In addition, the isolates were tested for inducible clindamycin resistance. All prostate derived P. acnes isolates displayed wild-type distribution of MIC-values, without evidence of acquired resistance. In the reference panel, 5 of 25 isolates had acquired macrolide resistance with cross-resistance to azithromycin, clindamycin, and erythromycin. In addition, one of these isolates was resistant to tetracycline.

Place, publisher, year, edition, pages
2012. Vol. 120, no 10, 778-785 p.
Keyword [en]
Antibiotic; Cancer; Propionibacterium; Prostate; Prostatitis
National Category
Medical and Health Sciences
Research subject
Medicine
Identifiers
URN: urn:nbn:se:oru:diva-42796DOI: 10.1111/j.1600-0463.2012.02905.xISI: 000308578200002PubMedID: 22958285Scopus ID: 2-s2.0-8486615041OAI: oai:DiVA.org:oru-42796DiVA: diva2:789477
Note

Funding Agencies:

County Council of Vasterbotten (ALF)

Medical Faculty of Umeå University

Lions Cancer Research Foundation

Cancerforskningsfonden Norrland

Svenska Läkaresällskapet SLS-173871

Available from: 2015-02-19 Created: 2015-02-19 Last updated: 2017-03-27Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Davidsson, SabinaUnemo, MagnusAndersson, Swen-OlovAndrén, OveSöderquist, BoElgh, Fredrik
In the same journal
Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS)
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar

Altmetric score

Total: 288 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf